EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 359 filers reported holding EXELIXIS INC in Q1 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,894,715 | +10.2% | 269,781 | -3.6% | 0.02% | +20.0% |
| Q2 2023 | $5,349,883 | -7.4% | 279,952 | -5.9% | 0.02% | -11.8% |
| Q1 2023 | $5,775,154 | +11.5% | 297,535 | -7.9% | 0.02% | 0.0% |
| Q4 2022 | $5,179,765 | +1.2% | 322,928 | -1.1% | 0.02% | +6.2% |
| Q3 2022 | $5,119,000 | -28.1% | 326,451 | -4.6% | 0.02% | -15.8% |
| Q2 2022 | $7,122,000 | +10.3% | 342,095 | +20.1% | 0.02% | +46.2% |
| Q1 2022 | $6,459,000 | +838.8% | 284,934 | +656.8% | 0.01% | +1200.0% |
| Q4 2021 | $688,000 | -16.1% | 37,648 | -3.0% | 0.00% | -50.0% |
| Q3 2021 | $820,000 | +21.7% | 38,796 | +5.0% | 0.00% | +100.0% |
| Q2 2021 | $674,000 | -23.5% | 36,966 | -5.2% | 0.00% | -50.0% |
| Q1 2021 | $881,000 | -86.4% | 38,987 | -87.9% | 0.00% | -86.7% |
| Q4 2020 | $6,477,000 | -18.2% | 322,717 | -0.4% | 0.02% | -25.0% |
| Q3 2020 | $7,919,000 | +3.2% | 323,897 | +0.2% | 0.02% | -4.8% |
| Q2 2020 | $7,671,000 | +999.0% | 323,127 | +697.5% | 0.02% | +950.0% |
| Q1 2020 | $698,000 | -6.3% | 40,518 | -4.2% | 0.00% | 0.0% |
| Q4 2019 | $745,000 | -0.4% | 42,288 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $748,000 | -17.9% | 42,288 | -0.7% | 0.00% | -33.3% |
| Q2 2019 | $911,000 | -30.4% | 42,607 | -22.5% | 0.00% | -25.0% |
| Q1 2019 | $1,308,000 | +18.1% | 54,948 | -2.4% | 0.00% | 0.0% |
| Q4 2018 | $1,108,000 | +11.0% | 56,323 | 0.0% | 0.00% | +33.3% |
| Q3 2018 | $998,000 | -19.5% | 56,323 | -2.2% | 0.00% | -25.0% |
| Q2 2018 | $1,240,000 | -4.5% | 57,603 | -1.8% | 0.00% | 0.0% |
| Q1 2018 | $1,299,000 | -28.0% | 58,633 | -1.2% | 0.00% | -20.0% |
| Q4 2017 | $1,803,000 | +26.5% | 59,322 | +0.9% | 0.01% | +25.0% |
| Q3 2017 | $1,425,000 | +0.5% | 58,822 | +2.1% | 0.00% | -20.0% |
| Q2 2017 | $1,418,000 | – | 57,590 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |